Clustering of immunoreceptor tyrosine-based activation motif-containing signalling subunits in CD4+ T cells is an optimal signal for IFN-γ production, but not for the production of IL-4

International Immunology

Volumn 15, Issue 5, 2003, Pages 665-677

  Annenkov, Alexander E ^a,c   Daly, Gordon M ^a   Brocker, Thomas ^b   Chernajovsky, Yuti ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cytokine; Gene therapy; Mouse; Th1; Th2; TCR

Indexed keywords

COLLAGEN ANTIBODY; COLLAGEN TYPE 2; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 4; KEYHOLE LIMPET HEMOCYANIN; MONOCLONAL ANTIBODY; PROTEIN SUBUNIT; RETROVIRUS VECTOR; TYROSINE;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTHRITIS; ARTICLE; ARTICULAR CARTILAGE; AUTOIMMUNE DISEASE; CELL MIGRATION; CHIMERA; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE THERAPY; GENE TRANSFER; GENETIC ENGINEERING; GENETIC TRANSDUCTION; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; TISSUE SPECIFICITY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; INTERFERON TYPE II; INTERLEUKIN-4; MICE; MICE, INBRED DBA; SIGNAL TRANSDUCTION; TH1 CELLS; TH2 CELLS; TYROSINE;

EID: 0037406181     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxg064     Document Type: Article

References (53)

1. Sakaguchi, S., Sakaguchi, N., Asano, M,, Itoh, M. and Toda, M. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). J. Immunol. 155:1151.
2. + T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 179:589.
3. + β islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 182:87.
4. Chen, L. Z., Hochwald, G. M., Huang, C., Dakin, G., Tao, H., Cheng, C., Simmons, W. J., Dranoff, G. and Thorbecke, G. J. 1998. Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-β1. Proc. Natl Acad. Sci. USA 95:12516.
5. h2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. J. Immunol. 155:4052.
6. h2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
7. + T cell clone that suppresses autoimmune diabetes in non-obese diabetic mice. Int. Immunol. 8:689.
8. Chernajovsky, Y., Adams, G., Podhajcer, O. L., Mueller, G. M., Robbins, P. D. and Feldmann, M. 1995. Inhibition of transfer of collagen-induced arthritis into SCID mice by ex vivo infection of spleen cells with retroviruses expressing soluble tumor necrosis factor receptor. Gene Ther. 2:731.
9. Chernajovsky, Y., Adams, G., Triantaphyllopoulos, K., Ledda, M. F. and Podhajcer, O. L. 1997. Pathogenic lymphoid cells engineered to express TGF β1 ameliorate disease in a collagen-induced arthritis model. Gene Ther. 4:553.
10. Mageed, R. A., Adams, G., Woodrow, D., Podhajcer, O. L. and Chernajovsky, Y. 1998. Prevention of collagen-induced arthritis by gene delivery of soluble p75 tumour necrosis factor receptor. Gene Ther. 5:1584.
11. Nakajima, A., Seroogy, C. M., Sandora, M, R., Tarner, I. H., Costa, G. L., Taylor-Edwards, C., Bachmann, M. H., Contag, C. H. and Fathman, C. G. 2001. Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. J. Clin. Invest. 107:1293.
12. Dreja, H., Annenkov, A. and Chernajovsky, Y. 2000. Soluble complement receptor 1 (CD35) delivered by retrovirally infected syngeneic cells or by naked DNA injection prevents the progression of collagen-induced arthritis. Arthritis Rheum. 43:1698.
13. h1 lymphocytes. J. Clin. Invest. 98:1851.
14. Shaw, M. K., Lorens, J. B., Dhawan, A., DalCanto, R., Tse, H. Y., Tran, A. B., Bonpane, C., Eswaran, S. L., Brocke, S., Sarvetnick, N., Steinman, L., Nolan, G. P. and Fathman, C. G. 1997. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J. Exp. Med. 185:1711.
15. Mathisen, P. M., Yu, M., Johnson, J. M., Drazba, J. A. and Tuohy, V. K. 1997. Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells. J. Exp. Med. 186:159.
16. Kramer, R., Zhang, Y., Gehrmann, J., Gold, R., Thoenen, H. and Wekerle, H. 1995. Gene transfer through the blood-nerve barrier: NGF-engineered neuritogenic T lymphocytes attenuate experimental autoimmune neuritis. Nat. Med. 1:1162.
17. Reth, M. 1989. Antigen receptor tail clue. Nature 338:383.
18. Annenkov, A. E., Moyes, S. P., Eshhar, Z., Mageed, R. A. and Chernajovsky, Y. 1998. Loss of original antigenic specificity in T cell hybridomas transduced with a chimeric receptor containing single-chain Fv of an anti-collagen antibody and FcεRI-signaling γ subunit. J. Immunol. 161:6604.
19. Annenkov, A. and Chernajovsky, Y. 2000. Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR ζ. Gene Ther. 7:714.
20. Annenkov, A. E., Daly, G. M. and Chernajovsky, Y. 2002. Highly efficient gene transfer into antigen-specific primary mouse lymphocytes with replication-deficient retrovirus expressing the 10A1 envelope protein. J. Gene Med. 4:133.
21. Holmdahl, R., Rubin, K., Klareskog, L., Larsson, E. and Wigzell, H. 1986. Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal ant-type II collagen antibodies. Arthritis Rheum. 29:400.
22. Ledbetter, J. A. and Herzenberg, L. A. 1979. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47:63.
23. Miller, E. J. 1972. Structural studies on cartilage collagen employing limited cleavage and solubilization with pepsin. Biochemistry 11:4903.
24. Ho, I. C., Hodge, M. R., Rooney, J. W. and Glimcher, L. H. 1996. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85:973.
25. Costa, G. L., Benson, J. M., Seroogy, C. M., Achacoso, P., Fathman, C. G. and Nolan, G. P. 2000. Targeting rare populations of murine antigen-specific T lymphocytes by retroviral transduction for potential application in gene therapy for autoimmune disease. J. Immunol. 164:3581.
26. + T cells. J. Exp. Med. 185:641.
27. Itoh, Y., Hemmer, B., Martin, R. and Germain, R. N. 1999. Serial TCR engagement and down-modulation by peptide:MHC molecule ligands: relationship to the quality of individual TCR signaling events. J. Immunol. 162:2073.
28. Hemmer, B., Stefanova, I., Vergelli, M., Germain, R. N. and Martin, R. 1998. Relationships among TCR ligand potency, thresholds for effector function elicitation, and the quality of early signaling events in human T cells. J. Immunol. 160:5807.
29. Valitutti, S., Muller, S., Cella, M., Padovan, E. and Lanzavecchia, A. 1995. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375:148.
30. Letourneur, F. and Klausner, R. D. 1991. T-cell and basophil activation through the cytoplasmic tail of the T-cell-receptor ζ family protein. Proc. Natl Acad. Sci. USA 88:8905.
31. Irving, B. A. and Weiss, A. 1991. The cytoplasmic domain of the Fc receptor ζ chain is sufficient to couple to receptor-associated signal transduction pathway. Cell 64:891.
32. Vivier, E., Rochet, N., Ackerly, M., Petrini, J., Levine, H., Daley, J. and Anderson, P. 1992. Signalling functions of reconstituted CD16:ζ:γ receptor complex isoforms. Int. Immunol. 4:1313.
33. Eshhar, Z., Walks, T., Gross, G. and Schindler, D. G. 1993. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody binding domains and the γ or ζ subunits of the immunoglobulin and T-cell receptors. Proc. Natl Acad. Sci. USA 90:720.
34. Brocker, T. and Karjalainen, K. 1995. Signals through T cell receptor-ζ chain alone are insufficient to prime resting T lymphocytes. J. Exp. Med. 181:1653.
35. Romeo, C., Amiot, M. and Seed, B. 1992. Sequence requirements for induction of cytolysis by the T cell antigen/Fc receptor ζ chain. Cell 68:889.
36. Brocker, T., Peter, A., Traunecker, A. and Karjalainen, K. 1993. New simplified molecular design for functional T cell receptor. Eur. J. Immunol. 23:1435.
37. Pages, F., Ragueneau, M., Rottapel, R., Truneh, A., Nunes, J., Imbert, J. and Olive, D. 1994. Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling. Nature 369:327.
38. King, P. D., Sadra, A., Teng, J. M., Xiao-Rong, L., Han, A., Selvakumar, A., August, A. and Dupont, B. 1997. Analysis of CD28 cytoplasmic tail tyrosine residues as regulators and substrates for the protein tyrosine kinases, EMT and LCK. J. Immunol. 158:580.
39. h2 effector cells. J. Immunol. 162:7110.
40. Gonzalo, J.-A., Delaney, T., Corcoran, J., Goodearl, A., Gutierrez-Ramos, J. C. and Coyle, A. J. 2001. Cutting edge: the related molecules CD28 and inducible costimulator deliver both unique and complementary signals required for optimal T cell activation. J. Immunol. 166:1.
41. Riley, J. L., Blair, P. J., Musser, J. T., Abe, R., Tezuka, K., Tsuji, T. and June, C. H. 2001. ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement. J. Immunol. 166:4943.
42. Tamada, K., Shimozaki, K., Chapoval, A. I., Zhai, Y., Su, J., Chen, S.-F., Hsieh, S.-L., Nagata, S., Ni, J. and Chen, L. 2000. LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J. Immunol. 164:4105.
43. Tamura, H., Dong, H., Zhu, G., Sica, G. L., Flies, D. B., Tamada, K. and Chen, L. 2001. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood 97:1809.
44. Tseng, S.-Y., Otsuji, M., Gorski, K., Huang, X., Slansky, J. E., Pai, S. I., Shalabi, A., Shin, T., Pardoll, D. M. and Tsuchiya, H. 2001. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 193:839.
45. Wang, S., Zhu, G., Chapoval, A. I., Dong, H., Tamada, K., Ni, J. and Chen, L. 2000. Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood 96:2808.
46. h subset differentiation. Int. Immunol. 10:577.
47. Hehner, S. P., Li-Weber, M., Giaisi, M., Droge, W., Krammer, P. H. and Schmitz, M. L. 2000. Vav synergizes with protein kinase Cθ to mediate IL-4 gene expression in response to CD28 costimulation in T cells. J. Immunol. 164:3829.
48. + T cells. Immunity 11:399.
49. h2 lymphocytes. J. Immunol. 164:1153.
50. Sloan-Lancaster, J., Steinberg, T. and Allen, P. 1997. Selective loss of the calcium ion signaling pathway in T cells maturing toward a T helper 2 phenotype. J. Immunol. 159:1160.
51. Crabtree, G. R. and Clipstone, N. A. 1994. Signal transmission between the plasma membrane and nucleus of T lymphocytes. Annu. Rev. Biochem. 63:1045.
52. Geisler, C. 1992. Failure to synthesize the CD3-γ chain. Consequences for T cell antigen receptor assembly, processing, and expression. J. Immunol. 148:2437.
53. Geiger, T. L., Nguyen, P., Leitenberg, D. and Flavell, R. A. 2001. Integrated src kinase and costimulatory activity enhances signal transduction through single-chain chimeric receptors in T lymphocytes. Blood 98:2364.